About the Authors
- Heather MacTavish
-
Contributed equally to this work with: Heather MacTavish, Jean-Simon Diallo
Affiliations Center for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada, University of Ottawa, Ottawa, Ontario, Canada
- Jean-Simon Diallo
-
Contributed equally to this work with: Heather MacTavish, Jean-Simon Diallo
Affiliations Center for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada, University of Ottawa, Ottawa, Ontario, Canada
- Baocheng Huang
-
Affiliation Departments of Surgery and Immunology, University of Pittsburgh Cancer Institute, Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America
- Marianne Stanford
-
Affiliations Center for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada, University of Ottawa, Ottawa, Ontario, Canada
- Fabrice Le Boeuf
-
Affiliations Center for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada, University of Ottawa, Ottawa, Ontario, Canada
- Naomi De Silva
-
Affiliations Center for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada, University of Ottawa, Ottawa, Ontario, Canada
- Julie Cox
-
Affiliations Center for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada, University of Ottawa, Ottawa, Ontario, Canada
- John Graydon Simmons
-
Affiliations Center for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada, University of Ottawa, Ottawa, Ontario, Canada
- Tanya Guimond
-
Affiliation Center for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
- Theresa Falls
-
Affiliation Center for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
- J. Andrea McCart
-
Affiliation Division of Experimental Therapeutics, Toronto General Research Institute, Toronto, Ontario, Canada
- Harry Atkins
-
Affiliations Center for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada, University of Ottawa, Ottawa, Ontario, Canada
- Caroline Breitbach
-
Affiliation Jennerex Biotherapeutics, Ltd., San Francisco, California, United States of America
- David Kirn
-
Affiliation Jennerex Biotherapeutics, Ltd., San Francisco, California, United States of America
- Stephen Thorne
-
Affiliations Departments of Surgery and Immunology, University of Pittsburgh Cancer Institute, Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America, Jennerex Biotherapeutics, Ltd., San Francisco, California, United States of America
- John C. Bell
-
* E-mail: jbell@ohri.ca
Affiliations Center for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada, University of Ottawa, Ottawa, Ontario, Canada, Jennerex Biotherapeutics, Ltd., San Francisco, California, United States of America
Competing Interests
JB, DK, ST and CB are affiliated with and/or employed by Jennerex Biotherapeutics. However, no direct financial support was provided by Jennerex for the completion of this study.
Author Contributions
Conceived and designed the experiments: HM JSD BH MMMS HA SHT JCB. Performed the experiments: HM JSD BH MMMS FLB NDS JC JGS TG TF. Analyzed the data: HM JSD BH MMMS. Contributed reagents/materials/analysis tools: FLB JAM DK SHT JCB. Wrote the paper: HM JSD CB JCB.